ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,97
-0,09%
Dow Jones
39 069,59
0,01%
DAX
18 693,37
0,04%
Brent Oil
81,965
0,00%
Bitcoin
69 288,04
1,11%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Capstone Therapeutics Corporation (QB) (CAPS)

  7. Capstone Therapeutics Corporation (QB) (CAPS) Actualités

CAPS

Capstone Therapeutics (QB) (CAPS)

Capstone Therapeutics Corporation (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:CAPS
DateHeureSourceTitreSymboleSociété
25/09/201922h01Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
09/09/201915h02Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/08/201922h00Edgar (US Regulatory)Current Report Filing (8-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
20/08/201923h25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/08/201915h02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:CAPSCapstone Therapeutics Corporation (QB)
10/07/201922h02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
03/07/201920h41Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201922h48Edgar (US Regulatory)Statement of Ownership: Private Transaction (sc 13e3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
31/05/201922h04Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
22/03/201921h04Edgar (US Regulatory)Annual Report (10-k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
21/03/201914h03Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
13/02/201922h46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/02/201919h02Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
04/02/201921h53Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:CAPSCapstone Therapeutics Corporation (QB)
28/12/201818h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:CAPSCapstone Therapeutics Corporation (QB)
30/10/201721h03Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
24/07/201723h11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:CAPSCapstone Therapeutics Corporation (QB)
17/07/201723h09Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:CAPSCapstone Therapeutics Corporation (QB)
19/04/201715h01Edgar (US Regulatory)Securities Registration (section 12(g)) (8-a12g)USOTC:CAPSCapstone Therapeutics Corporation (QB)
16/09/201515h04Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
26/06/201521h50Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:CAPSCapstone Therapeutics Corporation (QB)
23/06/201521h10Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/04/201521h46InvestorsHub NewsWireEDISON EQUITY RESEARCH - CAPSTONE THERAPEUTICSUSOTC:CAPSCapstone Therapeutics Corporation (QB)
24/06/201417h37Edgar (US Regulatory)Amended Securities Registration (section 12(g)) (8-a12g/a)USOTC:CAPSCapstone Therapeutics Corporation (QB)
24/06/201416h01Edgar (US Regulatory)(25)USOTC:CAPSCapstone Therapeutics Corporation (QB)
11/06/201418h47GlobeNewswire Inc.Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1b/2a Human Clinical Trial in Refractory Hypercholester...USOTC:CAPSCapstone Therapeutics Corporation (QB)
16/05/201419h00GlobeNewswire Inc.Capstone Therapeutics Announces Operating Update Conference CallUSOTC:CAPSCapstone Therapeutics Corporation (QB)
08/04/201415h00GlobeNewswire Inc.Capstone Therapeutics Announces Initiation of Dosing for AEM-28 Phase 1 Human Clinical Trial in LDL/non-HDL Cholesterol Reduc...USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/03/201414h02Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)USOTC:CAPSCapstone Therapeutics Corporation (QB)
27/03/201414h02Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)USOTC:CAPSCapstone Therapeutics Corporation (QB)
 Showing the most relevant articles for your search:USOTC:CAPS

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
FTSE
UKX
FTSE 100
EU
SGO
Cie de SaintGobain
EU
BEL20
Bel 20
EU
AF
Air FranceKLM
USI
USTECH100
US Tech 100
EU
VK
Vallourec
EU
VIV
Vivendi
EU
ACA
Credit Agricole
SPI
SP500
S&P 500
EU
GLE
Societe Generale
EU
ORA
Orange
NYSE
MRK
Merck
EU
BNP
BNP Paribas
EU
LR
Legrand
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés